Oncolytic Virus Therapy Market Size, Share, Growth, and Industry Analysis, By Types (HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses), By Applications (Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Others) , and Regional Insights and Forecast to 2035

Detailed TOC of Global Oncolytic Virus Therapy Market Research Report 2026

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 HSV-based Oncolytic Viruses
1.2.3 Adenoviruses-based Oncolytic Viruses
1.2.4 Vaccinia Virus-based Oncolytic Viruses
1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Oncolytic Virus Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Therapy Market Perspective (2020-2031)
2.2 Global Oncolytic Virus Therapy Growth Trends by Region
2.2.1 Global Oncolytic Virus Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncolytic Virus Therapy Historic Market Size by Region (2020-2026)
2.2.3 Oncolytic Virus Therapy Forecasted Market Size by Region (2026-2031)
2.3 Oncolytic Virus Therapy Market Dynamics
2.3.1 Oncolytic Virus Therapy Industry Trends
2.3.2 Oncolytic Virus Therapy Market Drivers
2.3.3 Oncolytic Virus Therapy Market Challenges
2.3.4 Oncolytic Virus Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Therapy Players by Revenue
3.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2020-2026)
3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2020-2026)
3.2 Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncolytic Virus Therapy Revenue
3.4 Global Oncolytic Virus Therapy Market Concentration Ratio
3.4.1 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Therapy Revenue in 2024
3.5 Global Key Players of Oncolytic Virus Therapy Head office and Area Served
3.6 Global Key Players of Oncolytic Virus Therapy, Product and Application
3.7 Global Key Players of Oncolytic Virus Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Therapy Breakdown Data by Type
4.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2020-2026)
4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2026-2031)
5 Oncolytic Virus Therapy Breakdown Data by Application
5.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2020-2026)
5.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncolytic Virus Therapy Market Size (2020-2031)
6.2 North America Oncolytic Virus Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncolytic Virus Therapy Market Size by Country (2020-2026)
6.4 North America Oncolytic Virus Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Therapy Market Size (2020-2031)
7.2 Europe Oncolytic Virus Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncolytic Virus Therapy Market Size by Country (2020-2026)
7.4 Europe Oncolytic Virus Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Therapy Market Size (2020-2031)
8.2 Asia-Pacific Oncolytic Virus Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2020-2026)
8.4 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Therapy Market Size (2020-2031)
9.2 Latin America Oncolytic Virus Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncolytic Virus Therapy Market Size by Country (2020-2026)
9.4 Latin America Oncolytic Virus Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Therapy Market Size (2020-2031)
10.2 Middle East & Africa Oncolytic Virus Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2020-2026)
10.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Oncolytic Virus Therapy Introduction
11.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.1.5 Amgen Recent Development
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Details
11.2.2 Oncolytics Biotech Business Overview
11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Introduction
11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.2.5 Oncolytics Biotech Recent Development
11.3 Viralytics
11.3.1 Viralytics Company Details
11.3.2 Viralytics Business Overview
11.3.3 Viralytics Oncolytic Virus Therapy Introduction
11.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.3.5 Viralytics Recent Development
11.4 Transgene SA
11.4.1 Transgene SA Company Details
11.4.2 Transgene SA Business Overview
11.4.3 Transgene SA Oncolytic Virus Therapy Introduction
11.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.4.5 Transgene SA Recent Development
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Details
11.5.2 Oncolys BioPharma Business Overview
11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Introduction
11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.5.5 Oncolys BioPharma Recent Development
11.6 Targovax
11.6.1 Targovax Company Details
11.6.2 Targovax Business Overview
11.6.3 Targovax Oncolytic Virus Therapy Introduction
11.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.6.5 Targovax Recent Development
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Details
11.7.2 PsiOxus Therapeutics Business Overview
11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Introduction
11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.7.5 PsiOxus Therapeutics Recent Development
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Details
11.8.2 SillaJen Biotherapeutics Business Overview
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Introduction
11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.8.5 SillaJen Biotherapeutics Recent Development
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Details
11.9.2 Sorrento Therapeutics Business Overview
11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Introduction
11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.9.5 Sorrento Therapeutics Recent Development
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Details
11.10.2 Lokon Pharma Business Overview
11.10.3 Lokon Pharma Oncolytic Virus Therapy Introduction
11.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.10.5 Lokon Pharma Recent Development
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Details
11.11.2 Genelux Corporation Business Overview
11.11.3 Genelux Corporation Oncolytic Virus Therapy Introduction
11.11.4 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.11.5 Genelux Corporation Recent Development
11.12 Vyriad
11.12.1 Vyriad Company Details
11.12.2 Vyriad Business Overview
11.12.3 Vyriad Oncolytic Virus Therapy Introduction
11.12.4 Vyriad Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.12.5 Vyriad Recent Development
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Details
11.13.2 TILT Biotherapeutics Business Overview
11.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Introduction
11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.13.5 TILT Biotherapeutics Recent Development
11.14 Cold Genesys
11.14.1 Cold Genesys Company Details
11.14.2 Cold Genesys Business Overview
11.14.3 Cold Genesys Oncolytic Virus Therapy Introduction
11.14.4 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2020-2026)
11.14.5 Cold Genesys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer